Literature DB >> 8406868

Passive immunizing activity of sera from mice infected with Borrelia burgdorferi.

S W Barthold1, L K Bockenstedt.   

Abstract

A single injection of serum from C3H mice at 90 days after intradermal inoculation with 10(4) Borrelia burgdorferi spirochetes protected naive mice when administered subcutaneously at -18 h relative to intradermal challenge inoculation with 10(4) B. burgdorferi spirochetes. When immune serum was given at intervals (-18, 0, +24, +48, and +96 h) relative to intradermal challenge with 10(4) B. burgdorferi spirochetes, it was protective if given before or at the time of challenge but not at later times. Protection with 90-day serum given at -18 h was effective at dilutions up to 1:32, but not 1:64, on the basis of culture or disease at either 5 or 15 days after challenge. Passive immunizing activity was also present in sera from mice at 21 days after intradermal challenge with 10(4), 10(2), or 10(1) spirochetes, indicating that the immunizing component was not dose dependent and probably not related to antibody to outer surface protein A. Passive immunizing titers of sera from mice at days 1, 15, 30, 90, 180, and 360 after intradermal B. burgdorferi inoculation appeared as early as day 15, were highest on day 30, and then declined progressively on days 90, 180, and 360. Immunizing titers of sera from mice at 360 days after intradermal B. burgdorferi inoculation were identical in passively immunized mice challenged with the original inoculum or with B. burgdorferi isolated at 360 days after inoculation, suggesting that there was no antigenic discrimination between the original inoculum and late isolates. These results suggest that protective antibody is produced early in the course of B. burgdorferi infection and is unrelated to antibody to outer surface protein A. In addition, the decline of protective serum titers over time despite persistent infection suggests that the antigens eliciting the protective response are either modified or suppressed, but antigenic modification could not be demonstrated.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8406868      PMCID: PMC281223          DOI: 10.1128/iai.61.11.4696-4702.1993

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  39 in total

1.  Characterization of the protective antibody response to Borrelia burgdorferi in experimentally infected LSH hamsters.

Authors:  J L Schmitz; R F Schell; S D Lovrich; S M Callister; J E Coe
Journal:  Infect Immun       Date:  1991-06       Impact factor: 3.441

2.  Persistence of Borrelia burgdorferi and histopathological alterations in experimentally infected animals. A comparison with histopathological findings in human Lyme disease.

Authors:  V Preac Mursic; E Patsouris; B Wilske; S Reinhardt; B Gross; P Mehraein
Journal:  Infection       Date:  1990 Nov-Dec       Impact factor: 3.553

3.  Kinetics of Borrelia burgdorferi dissemination and evolution of disease after intradermal inoculation of mice.

Authors:  S W Barthold; D H Persing; A L Armstrong; R A Peeples
Journal:  Am J Pathol       Date:  1991-08       Impact factor: 4.307

4.  Depletion of complement and effects on passive transfer of resistance to infection with Borrelia burgdorferi.

Authors:  J L Schmitz; S D Lovrich; S M Callister; R F Schell
Journal:  Infect Immun       Date:  1991-10       Impact factor: 3.441

5.  Molecular analysis and expression of a Borrelia burgdorferi gene encoding a 22 kDa protein (pC) in Escherichia coli.

Authors:  R Fuchs; S Jauris; F Lottspeich; V Preac-Mursic; B Wilske; E Soutschek
Journal:  Mol Microbiol       Date:  1992-02       Impact factor: 3.501

6.  Molecular mapping of Osp-A mediated immunity against Borrelia burgdorferi, the agent of Lyme disease.

Authors:  J E Sears; E Fikrig; T Y Nakagawa; K Deponte; N Marcantonio; F S Kantor; R A Flavell
Journal:  J Immunol       Date:  1991-09-15       Impact factor: 5.422

7.  Immunoglobulin G2 confers protection against Borrelia burgdorferi infection in LSH hamsters.

Authors:  J L Schmitz; R F Schell; S M Callister; S D Lovrich; S P Day; J E Coe
Journal:  Infect Immun       Date:  1992-07       Impact factor: 3.441

8.  Outer surface protein A (OspA) from the Lyme disease spirochete, Borrelia burgdorferi: high level expression and purification of a soluble recombinant form of OspA.

Authors:  J J Dunn; B N Lade; A G Barbour
Journal:  Protein Expr Purif       Date:  1990-11       Impact factor: 1.650

9.  Roles of OspA, OspB, and flagellin in protective immunity to Lyme borreliosis in laboratory mice.

Authors:  E Fikrig; S W Barthold; N Marcantonio; K Deponte; F S Kantor; R A Flavell
Journal:  Infect Immun       Date:  1992-02       Impact factor: 3.441

10.  Validity of western immunoblot band patterns in the serodiagnosis of Lyme borreliosis.

Authors:  L Zöller; S Burkard; H Schäfer
Journal:  J Clin Microbiol       Date:  1991-01       Impact factor: 5.948

View more
  58 in total

1.  Immunogenicity of Borrelia burgdorferi arthritis-related protein.

Authors:  Sunlian Feng; Emir Hodzic; Kimberly Freet; Stephen W Barthold
Journal:  Infect Immun       Date:  2003-12       Impact factor: 3.441

2.  Borrelia burgdorferi population dynamics and prototype gene expression during infection of immunocompetent and immunodeficient mice.

Authors:  Emir Hodzic; Sunlian Feng; Kim J Freet; Stephen W Barthold
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

3.  Relative contributions of innate and acquired host responses to bacterial control and arthritis development in Lyme disease.

Authors:  Xiaohui Wang; Ying Ma; John H Weis; James F Zachary; Carsten J Kirschning; Janis J Weis
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

4.  Duration of immunity to reinfection with tick-transmitted Borrelia burgdorferi in naturally infected mice.

Authors:  J Piesman; M C Dolan; C M Happ; B J Luft; S E Rooney; T N Mather; W T Golde
Journal:  Infect Immun       Date:  1997-10       Impact factor: 3.441

5.  Cloning and molecular characterization of plasmid-encoded antigens of Borrelia burgdorferi.

Authors:  J T Skare; D M Foley; S R Hernandez; D C Moore; D R Blanco; J N Miller; M A Lovett
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

6.  MyD88- and TRIF-independent induction of type I interferon drives naive B cell accumulation but not loss of lymph node architecture in Lyme disease.

Authors:  Christine J Hastey; Jennine Ochoa; Kimberley J Olsen; Stephen W Barthold; Nicole Baumgarth
Journal:  Infect Immun       Date:  2014-01-22       Impact factor: 3.441

7.  Specificity of infection-induced immunity among Borrelia burgdorferi sensu lato species.

Authors:  S W Barthold
Journal:  Infect Immun       Date:  1999-01       Impact factor: 3.441

8.  Expression and gene sequence of outer surface protein C of Borrelia burgdorferi reisolated from chronically infected mice.

Authors:  B Stevenson; L K Bockenstedt; S W Barthold
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

Review 9.  Biology of infection with Borrelia burgdorferi.

Authors:  Kit Tilly; Patricia A Rosa; Philip E Stewart
Journal:  Infect Dis Clin North Am       Date:  2008-06       Impact factor: 5.982

10.  Maternal Antibodies Provide Bank Voles with Strain-Specific Protection against Infection by the Lyme Disease Pathogen.

Authors:  Andrea Gomez-Chamorro; Vanina Heinrich; Anouk Sarr; Owen Roethlisberger; Dolores Genné; Cindy Bregnard; Maxime Jacquet; Maarten J Voordouw
Journal:  Appl Environ Microbiol       Date:  2019-11-14       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.